Tired of wondering why conference speaker panels are not more diverse, Christina Termini, PhD, MM,…
karnottOctober 16, 2024
During the height of the COVID-19 pandemic, about $23 billion flowed into U.S. federally qualified…
karnottOctober 16, 2024
ITHS is excited to welcome a new group of outstanding researchers to the TL1 Translational…
karnottOctober 15, 2024
Lundbeck has tapped Charles River Laboratories’ artificial intelligence capabilities to aid the discovery of neuroscience treatments, partnering…
karnottOctober 14, 2024
Kazushige Ninomiya, PhD, is conducting groundbreaking colorectal cancer research, and expanding his work into pancreatic…
karnottOctober 14, 2024
Human immunodeficiency virus type 1 (HIV-1) infection involves a selection bottleneck that leads to transmission…
karnottOctober 11, 2024
“T1D often starts at a very young age, and it’s a relentless, around-the-clock disease that…
karnottOctober 11, 2024
Nearly a decade ago, radio chemists at the nuclear power startup TerraPower saw a promising…
karnottOctober 10, 2024
University of Washington biochemist David Baker has won a share of this year’s Nobel Prize…
karnottOctober 10, 2024
